Published in
Springer, Breast Cancer Research and Treatment, 1(177), p. 231-232, 2019
DOI: 10.1007/s10549-019-05275-z
Links
Tools
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?
Journal article published in 2019 by
Roberta Maltoni 
,
Sara Bravaccini
,
Sara Bravaccini
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 